PROCEPT BioRobotics Corporation (PRCT) vs SiBone (SIBN)
PROCEPT BioRobotics Corporation and SiBone are both Medical Devices companies. PROCEPT BioRobotics Corporation is the larger, with a market value of $1.0B against $830.0M — 1.2× the size. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 15.3%. SiBone has the higher net margin (−6.85% vs −32.5%) and the higher return on invested capital (−15.4% vs −43.6%). Across the 18 metrics below, SiBone leads on 11 and PROCEPT BioRobotics Corporation on 7.
Valuation
Profitability
| Metric | PRCT | SIBN | Medical Devices median |
|---|---|---|---|
| Gross margin | 64.22% | 79.53% | 56.01% |
| Operating margin | (33.86%) | (8.31%) | (15.03%) |
| Net margin | (32.54%) | (6.85%) | (20.40%) |
| Free cash flow margin | (25.17%) | (2.05%) | (7.24%) |
| Return on equity | (30.24%) | (8.30%) | (15.32%) |
| Return on assets | (22.12%) | (6.10%) | (19.72%) |
| Return on invested capital | (43.57%) | (15.40%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack